Foldrx Pharmaceuticals' Series A Round

Foldrx Pharmaceuticals raised a round of funding on December 22, 2004.

FoldRx is a leader in the discovery and development of disease-modifying drug therapies for diseases of protein misfolding and amyloidosis.…

Articles about Foldrx Pharmaceuticals' Series A Round: